SLC29A1 and rheumatoid arthritis: This result suggests that no ENT1/2 dysregulation takes place in OA or RA synovial cells during inflammation, although the opposite has been reported in studies investigating inflammatory bowel disease in mice, where ENT1/2 inhibition dampened intestinal inflammation [44].